Neogen Chemicals Invests ₹100 Cr in Lithium Battery Materials Unit

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Neogen Chemicals Invests ₹100 Cr in Lithium Battery Materials Unit
Overview

Neogen Chemicals Ltd is investing ₹100.11 crore into its subsidiary, Neogen Morita New Material Limited (NML). This funding supports the company's expansion in the fast-growing lithium-ion battery materials sector, where it plans to develop key components like electrolyte salts. The investment also supports India's electric vehicle (EV) supply chain goals.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Neogen Chemicals Limited's board has approved investing ₹100.11 crore into its step-down subsidiary, Neogen Morita New Material Limited (NML). The investment involves subscribing to 71,00,000 equity shares at ₹141 per share via a rights issue. NML, established to develop and produce lithium-ion battery materials, will see its authorized share capital increase to ₹9.90 crore. This move signals Neogen's strong commitment to the strategic battery materials sector.

Why This Investment Matters

This investment supports Neogen Chemicals' strategy to grow in the fast-expanding lithium-ion battery materials market. This sector is vital for India's electric vehicle (EV) and renewable energy storage goals. Neogen plans to develop and produce key components such as electrolyte salts for both domestic and global customers, positioning itself as an important supplier in the EV battery ecosystem.

Company Background

Neogen Chemicals is a leading Indian maker of bromine-based and lithium-based specialty chemicals. The company produces intermediates for pharmaceutical, agrochemical, and specialty chemical industries. It has been expanding its lithium-based chemical offerings to target high-growth areas like electric vehicles and energy storage.

What This Means for Neogen

The capital infusion will enhance Neogen's capabilities in lithium-ion battery materials, giving NML the funds to scale operations and develop products. It aims to position Neogen as a more integrated part of the EV battery ecosystem and open new revenue channels in a rapidly growing global market.

Potential Risks

The lithium-ion battery sector offers growth but also challenges. Risks include difficulties in scaling up new material production, significant competition from global and domestic companies, and potential supply chain issues for raw materials.

Peer Landscape

Neogen's move into battery materials places it alongside other specialty chemical companies exploring this area. Tatva Chintaman is noted as a key player in battery materials, supplying electrolyte salts. Other diversified chemical companies like SRF Ltd. and Anupam Rasayan also have potential to expand into niche areas like advanced battery components.

Key Dates and Details

NML was incorporated on July 30, 2025. The board approved this rights issue subscription on April 28, 2026.

What to Watch Next

Investors will track the completion of the ₹100.11 crore share subscription within 60 days. Progress on NML's production facilities and commencement of electrolyte salt operations will be key. Also watch for NML's market entry strategy, securing offtake agreements, any future capacity expansion plans, and the new business vertical's contribution to Neogen's financial results.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.